Call Scheduled for Today at 6:30 PM ET SAN FRANCISCO, August 14, 2024 – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a conference call to discuss its second quarter … Continue reading “American Shared Hospital Services Announces Second Quarter 2024 Earnings Conference Call”
Breaking News
Formation Minerals, Inc. Provides Fiscal Year End Corporate Update
Jacksboro, Texas, August 14, 2024 – Formation Minerals, Inc. (OTCQB: FOMI) (“Formation” or the “Company”),…
Metatron Announces QuantumBeam – A Revolution in AI-Controlled Energy Transmission
Dover, DE, August 13th, 2024 – Metatron Apps Inc (OTC: MRNJ) ($MRNJ), leading developer of…
Sono-Tek Announces Additional $2.95 Million Order from Specialty Clean Energy Customer
4 System Order Expected to be Shipped in Fiscal 2026 Company Experiencing Strong Demand from…
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Case Series represents second study showing VitaGraft Kidney as a measure of response to the…
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
Company reports transformative second-quarter revenue, contributing to a record total of $116.4 million in revenue…
SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products
MIAMI, FL, August 12, 2024 – SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the…
AB INTL GROUP Reports of Financial Results for period ending May 31, 2024 and achieved Net Profitability
NEW YORK, August 12, 2024 — AB International Group Corp. (OTC: ABQQ), an intellectual property…
StemSation International Provides Corporate Updates
StemSation International is providing updates on corporate planning and direction as they execute on an…
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
Top Line Data Expected Year-End 2024 Pittsburgh, August 12, 2024 — Lipella Pharmaceuticals Inc. (Nasdaq:…
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
Melanocortin receptors on neurons in the brain control feeding and weight loss Patented peptide molecules…
Oncocyte Announces Successful GraftAssure Beta Launch and Q2 2024 Results
Interest in kidney transplant assay represents approximately 25% of US transplant volume Company lays out…
Premier Graphene President Pedro Mendez Meets with Global Leader in Sustainable Construction
Premier’s Graphene Suspensions Receiving Interest from one of the World’s Largest Materials Handling Companies EL…
ANEW MEDICAL, INC. Announces Patents Issued in Major Asian Markets for use of Genetic Therapy in the Treatment of Alzheimer’s Disease and ALS
Patents issued in mainland China protect the Company’s novel secreted Klotho protein and Its gene…